Prof. Jin Tao
Soochow University, China


2007 Ph.D., Pharmacology, Nanjing Medical University, China

2002 M.D., Clinical medicine, Nanjing Medical University, China

Publications (Selected)

  1. Wang F, Zhang Y, Jiang X, Zhang Y, Zhang L, Gong S, Liu C, Zhou L, Tao J*. Neuromedin U inhibits T-type Ca2+ channel currents and decreases membrane excitability in small dorsal root ganglia neurons in mice. Cell Calcium 2010 Nov 22. E-pub ahead of print.
  2. Xu G, Wang F, Jiang X, Tao J*. Aquaporin 1, a potential therapeutic target for migraine with aura. Molecular Pain 2010, 6, 68-76.
  3. Zhang Y, Jiang D, Zhang J, Wang F, Jiang X, Tao J*. Activation of neuromedin U type 1 receptor inhibits L-type Ca2+ channel currents via phosphatidylinositol 3-kinase-dependent protein kinase C epsilon pathway in mouse hippocampal neurons. Cellular Signalling 2010, 22, 1660-1668.
  4. Tao J*, Zhang Y, Huang H, Jiang XH. Activation of corticotropin-releasing factor 2 receptor inhibits Purkinje neuron P-type calcium currents via Goα-dependent PKC eposilon pathway. Cellular Signaling. Accepted, 2009. (*corresponding author)
  5. Tao J, Zhang Y, Li S, Sun W, Soong TW. Tyrosine kinase-independent inhibition by genistein on spermatogenic T-type calcium channels attenuates mouse sperm motility and acrosome reaction. Cell Calcium. 2009, 45(2):133-143.
  6. Guan X, Tao J, Li S Dopamine D1 receptor, but not dopamine D2 receptor, is a critical regulator for acute cocaine-enhanced gene expression. Neurological Research 2009, 31(1):17-22.
  7. Tao J, Hildebrand ME, Liao P, Liang MC, Tan G, Li S, Snutch TP, Soong TW. Activation of corticotropin-releasing factor receptor 1 selectively inhibits CaV3.2 T-type calcium channels. Molecular Pharmacology 2008, 73(6):1596-1609.